Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT02517086 Not yet recruiting - Breast Cancer Clinical Trials

Vascular Changes Due to Different Treatments of Lymphedema Secondary to Postoperative Breast Cancer

Start date: August 2015
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the effect of elastic compression, functional compressive bandaging (ECF) and active exercises in the bloodstream of the upper member ipsilateral to the surgical procedure for the treatment of breast cancer.

NCT ID: NCT02493569 Not yet recruiting - Breast Cancer Clinical Trials

A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China

Start date: October 2016
Phase: N/A
Study type: Observational

The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

NCT ID: NCT02488603 Not yet recruiting - Breast Cancer Clinical Trials

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

Start date: August 2015
Phase: N/A
Study type: Interventional

This is an educational intervention study for breast cancer patients who undergo tamoxifen treatment. The purpose of the study is to assess the impact of decision aids (DA) on the patients' decision-making process, compliance on drug, and knowledge regarding tamoxifen treatment. Patients will randomly assign to DA group or conventional group. Both groups will have baseline questionnaire surveys before starting tamoxifen treatment, and 4 weeks later follow-up questionnaire surveys.

NCT ID: NCT02464774 Not yet recruiting - Breast Cancer Clinical Trials

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Start date: July 2015
Phase: N/A
Study type: Interventional

RATIONALE: Triple-negative breast cancer (TNBC) is an aggressive subtype shown to have a high risk of locoregional recurrence (LRR) and distant metastasis (DM). The equivalent impact of breast-conserving therapy (BCT) and mastectomy on disease-free survival in patients with early breast cancer has been established by a number of large randomized controlled trials and meta-analysis. However, ongoing dispute exists on whether TNBC is a good candidate for BCT. PURPOSE: This prospective, randomized, open, single-center Phase III clinical study is conducted to compare efficacy and safety of breast-conserving therapy and mastectomy in treating Chinese patients with early TNBC.

NCT ID: NCT02448576 Not yet recruiting - Breast Cancer Clinical Trials

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

Start date: August 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare whether prophylactic cranial irradiation in patients with advanced triple negative breast cancer who had a response to first line chemotherapy could prolong brain-metastasis free survival.

NCT ID: NCT02416427 Not yet recruiting - Breast Neoplasms Clinical Trials

Targeting the Hippo Transducer TAZ in Breast Cancer With Statins

TRINACRIA
Start date: May 2015
Phase: Phase 2
Study type: Interventional

This pre-surgical, window-of-opportunity study is designed to investigate whether atorvastatin reduces the proliferation marker Ki-67 via modulation of the Hippo transducer TAZ.

NCT ID: NCT02353988 Not yet recruiting - Breast Neoplasms Clinical Trials

AR-inhibitor Bicalutamide in Treating Patients With TNBC

Arbre
Start date: January 2015
Phase: Phase 2
Study type: Interventional

Growing studies demonstrated that Androgen Receptor (AR) has an oncogenic role for the patients with AR-positive Triple Negative Breast Cancer (TNBC). AR antagonists in therapy, such as bicalutamide, completely binds to the AR, increasing AR degradation, thus are investigated for the efficacy of the treatment of patients with AR-positive TNBC in the study.

NCT ID: NCT02340494 Not yet recruiting - Breast Neoplasms Clinical Trials

An Online Enhanced Education Tool for Young Women Newly Diagnosed With Breast Cancer

Start date: April 2015
Phase: N/A
Study type: Interventional

This project proposes to develop and test an internet resource - a supported self-management website - that will guide younger women to relevant knowledge and resources, and provide tools that will help YWBC become more skilled and confident in coping with the many challenges of breast cancer. The study will be conducted in collaboration with the newly funded, pan-Canadian Young Breast Cancer Cohort (CYBCC) program being led from Women's College Hospital. The resource is expected to reduce knowledge gaps experienced by YWBC, and help them be partners in decision-making about their care, which has been shown to reduce anxiety and depression years later.

NCT ID: NCT02336529 Not yet recruiting - Breast Cancer Clinical Trials

Nerveblocks for Persistent Pain After Breast Cancer Surgery

Start date: July 2016
Phase: Phase 3
Study type: Interventional

Persistent pain after breast cancer surgery (PPBCS) affects 25-60% of breast cancer survivors and nerve damage has been implicated as the cause of this neuropathic pain condition. Local anaesthetic blockade of tenderpoints and the intercostobrachial nerve (ICBN) could provide clues to pathophysiological mechanisms as well as aiding diagnosis and treatment of PPBCS but has never been attempted. The aims of this study is to examine clinical effect of ultrasound guided blockades of the ICBN and tenderpoints of pain.

NCT ID: NCT02318615 Not yet recruiting - Lymphedema Clinical Trials

Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention

Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this comparable cohort study is to evaluate the efficacy and safety of immediate axillary plasty with pedicled partial Latissimus Dorsi muscle flap for lymphedema prevention in breast cancer patients who are undergoing axillary dissection.